Silvercrest Asset Management Group LLC Chembio Diagnostics, Inc. Transaction History

Silvercrest Asset Management Group LLC

  • $13.6 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$2.36 - $5.6 $1.61 Million - $3.81 Million
-681,189 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$3.94 - $5.76 $114,523 - $167,425
-29,067 Reduced 4.09%
681,189 $3.11 Million
Q3 2019

Nov 14, 2019
BUY
$4.84 - $7.25 $3.44 Million - $5.15 Million
710,256 New
710,256 $4.35 Million

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email